Federation des caisses Desjardins du Quebec’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.66M | Buy |
58,976
+10,052
| +21% | +$854K | 0.01% | 540 |
|
|
2026
Q1 | $4.22M | Sell |
48,924
-14,082
| -22% | -$1.26M | 0.02% | 499 |
|
|
2025
Q4 | $5.5M | Sell |
63,006
-15,899
| -20% | -$1.21M | 0.02% | 424 |
|
|
2025
Q3 | $4.52M | Buy |
78,905
+41,138
| +109% | +$2.37M | 0.02% | 443 |
|
|
2025
Q2 | $2.23M | Buy |
37,767
+13,700
| +57% | +$885K | 0.01% | 624 |
|
|
2025
Q1 | $1.76M | Sell |
24,067
-3,800
| -14% | -$314K | 0.01% | 658 |
|
|
2024
Q4 | $2.3M | Sell |
27,867
-4,482
| -14% | -$353K | 0.01% | 543 |
|
|
2024
Q3 | $2.31M | Sell |
32,349
-3,100
| -9% | -$219K | 0.01% | 538 |
|
|
2024
Q2 | $2.43M | Buy |
35,449
+8,400
| +31% | +$502K | 0.01% | 511 |
|
|
2024
Q1 | $1.44M | Hold |
27,049
| – | – | 0.01% | 607 |
|
|
2023
Q4 | $1.44M | Buy |
27,049
+12,697
| +88% | +$619K | 0.01% | 521 |
|
|
2023
Q3 | $713K | Sell |
14,352
-6,718
| -32% | -$376K | 0.01% | 669 |
|
|
2023
Q2 | $1.25M | Buy |
21,070
+10,700
| +103% | +$610K | 0.01% | 548 |
|
|
2023
Q1 | $587K | Buy |
10,370
+520
| +5% | +$33.3K | 0.01% | 715 |
|
|
2022
Q4 | $732K | Sell |
9,850
-4,650
| -32% | -$317K | 0.01% | 674 |
|
|
2022
Q3 | $864K | Buy |
14,500
+1,750
| +14% | +$105K | 0.01% | 623 |
|
|
2022
Q2 | $716K | Hold |
12,750
| – | – | 0.01% | 690 |
|
|
2022
Q1 | $941K | Buy |
12,750
+1,200
| +10% | +$83.4K | 0.01% | 666 |
|
|
2021
Q4 | $833K | Sell |
11,550
-3,900
| -25% | -$283K | 0.01% | 708 |
|
|
2021
Q3 | $1.18M | Sell |
15,450
-9,650
| -38% | -$775K | 0.01% | 644 |
|
|
2021
Q2 | $1.94M | Hold |
25,100
| – | – | 0.02% | 505 |
|
|
2021
Q1 | $1.55M | Sell |
25,100
-8,550
| -25% | -$541K | 0.02% | 563 |
|
|
2020
Q4 | $2.2M | Sell |
33,650
-13,600
| -29% | -$782K | 0.03% | 434 |
|
|
2020
Q3 | $2.35M | Sell |
47,250
-6,250
| -12% | -$322K | 0.03% | 349 |
|
|
2020
Q2 | $2.56M | Sell |
53,500
-3,500
| -6% | -$169K | 0.04% | 329 |
|
|
2020
Q1 | $2.45M | Buy |
57,000
+19,600
| +52% | +$968K | 0.04% | 315 |
|
|
2019
Q4 | $2.2M | Buy |
37,400
+4,200
| +13% | +$228K | 0.03% | 416 |
|
|
2019
Q3 | $1.7M | Buy |
33,200
+4,600
| +16% | +$219K | 0.02% | 480 |
|
|
2019
Q2 | $1.21M | Buy |
28,600
+2,996
| +12% | +$130K | 0.02% | 588 |
|
|
2019
Q1 | $1.26M | Buy |
25,604
+23,271
| +997% | +$1.05M | 0.02% | 532 |
|
|
2018
Q4 | $101K | Sell |
2,333
-521
| -18% | -$26K | ﹤0.01% | 1127 |
|
|
2018
Q3 | $162K | Buy |
2,854
+1
| +0% | +$53 | ﹤0.01% | 1073 |
|
|
2018
Q2 | $144K | Buy |
+2,853
| New | +$149K | ﹤0.01% | 1106 |
|
|
2017
Q4 | – | Sell |
-3,647
| Closed | -$108K | – | 2149 |
|
|
2017
Q3 | $108K | Buy |
3,647
+652
| +22% | +$19.9K | ﹤0.01% | 1142 |
|
|
2017
Q2 | $0 | Sell |
2,995
-71
| -2% | -$2.23K | ﹤0.01% | 2188 |
|
|
2017
Q1 | $90.7K | Buy |
+3,066
| New | +$83.7K | ﹤0.01% | 1042 |
|
Other funds holding GMED
Federation des caisses Desjardins du Quebec's GMED Position: Q2 2026 in Review
Federation des caisses Desjardins du Quebec increased its Globus Medical (GMED) stake by 21% in Q2 2026, buying an estimated $854K and bringing the position to 58,976 shares worth $4.66M. The position accounts for 0.01% of the portfolio, ranked #540.
Federation des caisses Desjardins du Quebec first reported a position in GMED in Q1 2017 and has held it in 36 quarters since. The position peaked at $5.5M in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Federation des caisses Desjardins du Quebec held 58,976 shares of Globus Medical worth $4.66M as of Q2 2026.
- Federation des caisses Desjardins du Quebec bought 10,052 Globus Medical shares in Q2 2026, an estimated $854K.
- Globus Medical made up 0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #540 holding.
- Federation des caisses Desjardins du Quebec first reported a position in Globus Medical in Q1 2017 and has held it in 36 quarters since.
- Federation des caisses Desjardins du Quebec's Globus Medical position peaked at $5.5M in Q4 2025.
- 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.